{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
{{cardData.Tag}}
{{cardData.CtaText}}
{{cardData.Title}}
{{cardData.TimeSignatureField}}
Video transcript
-
Kirkland Advises McDermott on Refinancing, Strengthening Capital Structure for Continued Growth
- Kirkland Advises Francisco Partners on Investment in Rightway’s $155 Million Series E Financing
- Kirkland Advises Form Energy on Close of $270 Million Credit Facility
- Kirkland Advises KKR on Launch of Akrapoint Commercial Capital
- Kirkland Advises Bridgepoint on Acquisition of Altano
- Kirkland Advises Ares on Acquisition of Stake in U.S. Solar and Battery Portfolio from EDPR
- Kirkland Wins “Turnaround and Transaction of the Year” Award
- For 17th Straight Year, Kirkland Among BTI’s “Fearsome Foursome”
- Kirkland Advises ARCHIMED on Final Close of Oversubscribed €1.5 Billion MED IV Fund
- Kirkland Advises Royal Caribbean Group on Partnership with Sandals Resorts at $6 Billion Enterprise Value
- Kirkland Advises Butterfly Equity on Acquisition of Sabert
- Kirkland Advises EQT on First Long-Term Gas Supply Contract Between Lithuania and the U.S.
- The EU Cyber Resilience Act: Preparing for the New Reporting Obligations for “Products With Digital Elements”
- Kirkland Advises TPG on Investment in Crusoe’s $3.9 Billion Series F for its Vertically Integrated AI Infrastructure Platform
- Partners Kevin Ehrhart and Robert Keane Named “Commercial Real Estate Visionaries” by LA Times Studios
- Kirkland Advises Argano on Acquisition of GoSaaS
- Kirkland Advises AKTIV Against Cancer on Merger with CancerFit
- Kirkland Advises Alpine Investors on its Establishment of Eight Group Service Partners
- Kirkland Advises H.I.G. Capital on Acquisition of MISTRAS
- Litigators of the Week: A Philadelphia Defense Verdict in First Neutrogena Sunscreen Recall Trial